Intrauterine Exposure to Diabetes and Risk of Cardiovascular Disease in Adolescence and Early Adulthood: a Population-based Birth Cohort Study
Overview
Authors
Affiliations
Background: It is unclear whether intrauterine exposure to maternal diabetes is associated with risk factors for cardiovascular disease and related end points in adulthood. We examined this potential association in a population-based birth cohort followed up to age 35 years.
Methods: We performed a cohort study of offspring born between 1979 and 2005 ( = 293 546) and followed until March 2015 in Manitoba, Canada, using registry-based administrative data. The primary exposures were intrauterine exposure to gestational diabetes and type 2 diabetes mellitus. The primary outcome was a composite measure of incident cardiovascular disease events, and the secondary outcome was a composite of risk factors for cardiovascular disease in offspring followed up to age 35 years.
Results: The cohort provided 3 628 576 person-years of data (mean age at latest follow-up 20.5 [standard deviation 6.4] years, 49.3% female); 2765 (0.9%) of the offspring experienced a cardiovascular disease end point, and 12 673 (4.3%) experienced a cardiovascular disease risk factor. After propensity score matching, the hazard for cardiovascular disease end points was elevated in offspring exposed to gestational diabetes (adjusted hazard ratio [HR] 1.42, 95% confidence interval [CI] 1.12-1.79) but not type 2 diabetes (adjusted HR 1.40, 95% CI 0.98-2.01). A similar association was observed for cardiovascular disease risk factors (gestational diabetes: adjusted HR 1.92, 95% CI 1.75-2.11; type 2 diabetes: adjusted HR 3.40, 95% CI 3.00-3.85).
Interpretation: Intrauterine exposure to maternal diabetes was associated with higher morbidity and risk related to cardiovascular disease among offspring up to 35 years of age.
Chen A, Tan B, Du R, Chong Y, Zhang C, Koh A Cardiovasc Diabetol. 2024; 23(1):320.
PMID: 39198842 PMC: 11360578. DOI: 10.1186/s12933-024-02416-7.
DNA methylation signatures of youth-onset type 2 diabetes and exposure to maternal diabetes.
Salama O, Hizon N, Del Vecchio M, Kolsun K, Fonseca M, Lin D Clin Epigenetics. 2024; 16(1):65.
PMID: 38741114 PMC: 11092083. DOI: 10.1186/s13148-024-01675-1.
Song C, Ouyang F, Ma T, Gong L, Cheng X, Bai Y SSM Popul Health. 2024; 25:101634.
PMID: 38434445 PMC: 10907827. DOI: 10.1016/j.ssmph.2024.101634.
Diabetes Mellitus and Pregnancy: An Insight into the Effects on the Epigenome.
Meza-Leon A, Montoya-Estrada A, Reyes-Munoz E, Romo-Yanez J Biomedicines. 2024; 12(2).
PMID: 38397953 PMC: 10886464. DOI: 10.3390/biomedicines12020351.
Wang Y, Yuan Y, Shen S, Ge Z, Zhu D, Bi Y Front Endocrinol (Lausanne). 2024; 14:1282075.
PMID: 38260139 PMC: 10800463. DOI: 10.3389/fendo.2023.1282075.